During the past decade, Royal London conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal London" #1 collaborator was "ResearchPoint Global" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Royal London" are "Cancer" (1 trials), "Cerebrovascular Stroke" (1 trials), "Spinal Fractures" (1 trials) and "Upper Extremity Paresis" (1 trials). Many other conditions were trialed in "Royal London" in a lesser frequency.

Most popular intervention types in "Royal London" are "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Balloon Kyphoplasty" (1 trials), "Non Surgical Management" (1 trials), "Paired Vagus Nerve Stimulation" (1 trials) and "Rehabilitation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal London" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Royal London". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Royal London, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal London, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".